Publications
This video focuses on the Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program’s interventions that have improved care and reduced hospital length of stay, NICU admissions, and need for pharmacologic treatment for opioid-exposed newborns and their mothers.
The Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program tested interventions to improve quality of care for opioid-exposed newborns and their mothers. This report evaluates the impact of both the NAS investment program and of specific interventions.
This impact brief focuses on successful quality improvement interventions from the Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program for families impacted by opioid use disorder, including increasing non-pharmacologic interventions, optimizing pharmacologic treatment and hospital utilization, and improving access to wraparound treatments.
This impact brief includes an overview of the Targeted Cost Challenge Investments program including program awardees, implemented care models, and the impacts of these initiatives.
Profile on Hebrew Senior Life’s response to COVID-19, including utilizing components of an existing HPC-funded program—the Right Care, Right Place, Right Time (R3) program—to inform the system they put in place to meet the needs of all residents during the pandemic.
This brief shares lessons learned from the HPC’s Health Care Innovation Investment (HCII) program on successfully sustaining grant-funded initiatives.
The Telemedicine Pilot Investment Program was designed to demonstrate the potential of telemedicine to address behavioral health access challenges in high-need populations across the Commonwealth. This report includes case studies of the four awardee organizations, analyzes program impact, and provides insights from the pilot program and ongoing considerations for telehealth.